Wuhan General Group (China), Inc. (WUHN)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 9, 2025
Wuhan General Group (China) Company Description
Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr.
AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness.
The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others.
Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.
Wuhan General Group (China), Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 700 |
| CEO | Jeffrey Robinson |
Contact Details
Address: 6500 Transcanada hwy Pointe-Claire, Nevada H9R 0A5 Canada | |
| Phone | 514-928-7368 |
| Website | wuhn.org |
Stock Details
| Ticker Symbol | WUHN |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US9825691051 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey Robinson | Founder, Chairman and Chief Executive Officer |
| Carol Pan | Principal Financial Officer, Principal Accounting Officer and Treasurer |
| Willem Jonker | Chief Operating Officer |
| Dr. Hyder Ali Khoja A.Ag., M.Sc., Ph.D. | Chief Scientific Officer |
| Shivani Subudhi | Head of Marketing |
| Huang Zhaoqi | Vice General Manager of Turbine and Director |
| Dr. Anna Leralta Morera | Chief Medical Officer |
| Samuel Williams | Head of Food Formulations and Functional Foods |
| Clementine Toto | Head of African Aromatherapy |
| Nicola Royce | Managing Director of M2Biome |